2011 J. L. Sherley and J. R. Merok, “Unique Properties of Stem Cells,” U.S. Patent No. 7,883,891.

2011 J. L. Sherley and M.-S. Noh, “Nucleic Acid Sequences Associated with Cell States,” U.S. Patent No. 7,867,712 B2.

2010 J. L. Sherley and J. King, “Methods for Ex Vivo Propagation of Somatic Hair Follicle Stem Cells,” U.S. Patent No. 7,655,465 B2.

2010 J. L. Sherley and K. Panchalingam, “Methods for Ex Vivo Propagation of Adult Hepatic Stem Cells,” U.S. Patent No. 7,824,912 B2.

2010 J. L. Sherley, H.-S. Lee, and G.G. Crane, "Hepatocyte Precursor Cell Lines," U.S. Patent No. 7,645,610 B2.


PENDING APPLICATIONS


2013 J. L. Sherley and Y. H. Huh, “Detecting and Counting Tissue-Specific Stem Cells and Uses Thereof,” US2013/0004965A1


2014 J. L. Sherley and J.-F., Pare,“ Methods for Producing Human Pancreatic Islet Precursor Cells and Uses Thereof.” International Application No. PCT/US2012/042644.">
apposters.com
Asymmetrex, LLC
Edit

Asymmetrex, LLC

https://asymmetrex.com/
Last activity: 29.10.2024
Active
Categories: AppBioTechCenterDrugEngineeringFutureHealthTechHumanProductionTechnology
Asymmetrex, LLC has a rich portfolio of stem cell technologies available for licensing. Depending on the technology and the planned use, both non-exclusive and exclusive licensing arrangements can be developed.

PATENTED TECHNOLOGIES

2014 J. L. Sherley and J.-F. Paré, “Method for Cloning Pluripotent Stem Cells,” U.S. Patent No. 8,759,098 B2.

2013 J. L. Sherley, H.-S. Lee, and G.G. Crane, "Hepatocyte Precursor Cell Lines," U.S. Patent No. 8,404,481 B2.

2011 J. L. Sherley and J. R. Merok, “Unique Properties of Stem Cells,” U.S. Patent No. 7,883,891.

2011 J. L. Sherley and M.-S. Noh, “Nucleic Acid Sequences Associated with Cell States,” U.S. Patent No. 7,867,712 B2.

2010 J. L. Sherley and J. King, “Methods for Ex Vivo Propagation of Somatic Hair Follicle Stem Cells,” U.S. Patent No. 7,655,465 B2.

2010 J. L. Sherley and K. Panchalingam, “Methods for Ex Vivo Propagation of Adult Hepatic Stem Cells,” U.S. Patent No. 7,824,912 B2.

2010 J. L. Sherley, H.-S. Lee, and G.G. Crane, "Hepatocyte Precursor Cell Lines," U.S. Patent No. 7,645,610 B2.


PENDING APPLICATIONS


2013 J. L. Sherley and Y. H. Huh, “Detecting and Counting Tissue-Specific Stem Cells and Uses Thereof,” US2013/0004965A1


2014 J. L. Sherley and J.-F., Pare,“ Methods for Producing Human Pancreatic Islet Precursor Cells and Uses Thereof.” International Application No. PCT/US2012/042644.
Likes
2.82K
Followers
753
Mentions
19
Location: United States, Massachusetts, Boston
Employees: 11-50
Phone: +1 617-990-6819
Founded date: 2013

Mentions in press and media 19

DateTitleDescription
29.10.2024Asymmetrex® Presents the Impact of Differential Stem Cell Counting for Cultured Meat ProductionThe Asymmetrex® Specialty Asymmetrex®'s differential stem cell counting impacts the cultured meat industry Last week, in The GFI’s cultured meat industry monthly forum, Asymmetrex® discussed how its differential stem cell counting technolog...
02.10.2024Asymmetrex® Awarded $1.8M NIH-NHLBI SBIR Phase II Grant to Manufacture First Differential Tissue Stem Cell CounterThe future of stem cell science and medicine: Automated Differential Tissue Stem Cell Counting Asymmetrex® LLC Asymmetrex® CEO, James L. Sherley, MD, PhD Asymmetrex® was awarded a $1.8M NHLBI grant to develop an instrument for automated det...
28.02.2023Asymmetrex® Publishes First Rating of the Effects of Commercial Growth Factors Used for Stem Cell BiomanufacturingNew stem cell biomanufacturing report from Asymmetrex® Asymmetrex® Rates Commercial Growth Factors’ Effects on Mesenchymal Stem Cells. It’s the ability to count tissue stem cells specifically at any time that makes all the rest possible And...
14.12.2022Asymmetrex® Announces Plan to Develop the First Automated Electronic Cell Counter for Therapeutic Stem CellsAsymmetrex's now validated rapid stem cell-counting algorithms enable the development of the first automated electronic stem cell counters. Asymmetrex® announces plan to develop the first therapeutic stem cell counter based on new report of...
06.10.2022Asymmetrex® Discusses Impact of New Technologies for Stem Cell Dosage Determination on Outsourcing for Stem Cell Clinical Trials, Gene Therapy Clinical Trials, and PharmaAsymmetrex® Presents at OCTNE 2022 in Boston on October 12 Stem cell dosage determination will transform the stem cell clinical trials industry, including its outsourcing. BOSTON (PRWEB) October 06, 2022 The OCTNE 2022 conference, taking pl...
20.09.2022Asymmetrex® Gives First Cell Culture Core Facility Introduction to Online Rapid Stem Cell Counting in the Institute for Applied Life Sciences at UMassAmherstSeptember 20 Presentation on Technology for Rapid Stem Cell Counting After UMassAmherst in-person, the first national webinar in the core facility introduction series is scheduled a week later on September 27! BOSTON (PRWEB) September 20, 2...
13.09.2022Asymmetrex’s Introduction of Online Calculators for Determination of the Dosage of Therapeutic Stem Cells Announced as a Reformation in Stem Cell Science and MedicineConsole page from Asymmetrex® online calculator portal for determining the dosage of umbilical cord blood stem cells ...introduction of online rapid stem cell-counting calculators is the start of a reformation in stem cell science and medic...
04.08.2022Asymmetrex® Interviewed by Tech Company News About Plans to Introduce Online Rapid-Counting Calculators for Quantifying Therapeutic Tissue Stem CellsPreview of an online rapid stem cell-counting calculator portal page Counting tissue stem cells accurately and fast is something stem cell science and stem cell medicine have needed for a very long time. It’s here now,... BOSTON (PRWEB) Aug...
15.06.2022Asymmetrex®’s Kinetic Stem Cell (KSC) Counting Technology Is Featured in the Parent’s Guide to Cord Blood Foundation® June NewsletterThe Parent's Guide to Cord Blood features Asymmetrex's technology for determining the dosage of therapeutic cord blood stem cells. ...will help both non-experts and experts to understand how Asymmetrex counts therapeutic tissue stem cells. ...
09.06.2022Asymmetrex Presents New Developments in its Rapid Stem Cell Counting Technology at the ARMI|BioFabUSA Meeting in the Millyard on Regenerative Medicine BiomanufacturingAsymmetrex reports algorithms for rapid quantification of therapeutic stem cells "Determining the dose of therapeutic stem cells is now more than just possible for the first time. With ARMI’s support it's getting easy to do, too!"...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In